NDRA · ENDRA Life Sciences Inc.
$4.60
+0.03 (+0.55%)
At close · Aug 7
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has not established an ongoing source of revenue sufficient to cover its operating costs and to allow it to continue as a going concern and will require additional financing to fund its future planned operations, including research and development and commercialization of its products. These matters raise substantial doubt about the Company's ability to continue as going concern.”View the 10-Q filed May 15, 2026
Market Cap
$5.84M
Shares
1.27M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.60
Open$4.49
Day$4.35–4.60
52W$2.96–9.85
Avg vol 30d30K
Short int28K · 2.2% float · 1.0d
Short vol60%
Last earningsMar 31, 2025
DataJan 2020–Aug 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Strong
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.54
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−5%
below
Price vs 50-day avg
−7%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
24%
mid-range
Momentum
relative strength
1-month return
−18%
trailing
6-month return
+31%
trailing
YTD return
+2%
this year
Relative strength
+18%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
2 of 8 funds reported for Jun 30 · net +28.4K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.18% of float · ▼ -34.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
8 holders — mid 3-yr range
Squeeze score
33
low risk · 0–100
Fundamentals
EPS growth
+84%
Y/Y
Free cash flow
$-5.2M
Balance sheet
$0
net cash
Quant / Vol
risk profile
Volatility
106%
annualized · 1-yr
Max drawdown
−60%
past year
ATR
10.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−5%
Neutral
Price vs 50-day avg
−7%
Bearish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
24%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
2 of 8 funds reported for Jun 30 · net +28.4K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.18% of float · ▼ -34.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
8 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $3
Now $5 · 24%
52-wk high $10
vs 200-day avg -5%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NDRA
this stock
ENDRA Life Sciences Inc.
|
$5.84M | +1.5% | -100.0% | — | 2.2% |
|
TMO
Thermo Fisher Scientific Inc.
|
$219.63B | +2.7% | +0.4% | 32.0 | 1.4% |
|
DHR
Danaher Corp /De/
|
$143.94B | -10.2% | +8.5% | 36.3 | 1.4% |
|
NTRA
Natera, Inc.
|
$46.43B | +40.6% | -2.8% | — | 3.4% |
|
IDXX
Idexx Laboratories Inc /De
|
$46.22B | -13.3% | +10.4% | 41.2 | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NDRA | -2.1% | -18.0% | +31.1% | -2.1% | +1.6% |
| SPY | +3.5% | +2.4% | +13.4% | +3.5% | +13.4% |
| vs SPY | -5.6% | -20.4% | +17.6% | -5.6% | -11.8% |